Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00228865 · ClinicalTrials.gov registry record · Phase 2
Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1
A Phase 2 study, sponsored by Florida Atlantic University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
NCT00228865 is a Phase 2 study that was terminated before completion, run by Florida Atlantic University. The registered enrollment target is 75 participants.
The verdict
NCT00228865, a Phase 2 study, was terminated before completion, sponsored by Florida Atlantic University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
Study Summary
To determine if restoring normal metabolic function in patients with either Type I or Type II Diabetes can improve overall cognitive function. Patients are treated once a week with pulsatile intravenous insulin therapy mimicking normal insulin secretion and high amounts of oral glucose consumption.
Interventions
- PROCEDURE Pulsatile IV insulin therapy
- PROCEDURE Effects of Pulsatile IV Insulin on Cognitive functions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2003-06 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00228865
The ClinicalTrials.gov registry entry for NCT00228865 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida Atlantic University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pulsatile IV insulin therapy is the first listed.
NCT00228865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00228865 about?
NCT00228865 is a clinical study titled "Clinical Effects of Pulsatile Insulin Delivery on Cognitive Function- Phase 1". To determine if restoring normal metabolic function in patients with either Type I or Type II Diabetes can improve overall cognitive function. Patients are treated once a week with pulsatile intravenous insulin therapy mimicking normal insulin secretion and high amounts of oral glucose consumption.
What is the current status of trial NCT00228865?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2003-06. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00228865?
The interventions under investigation include: Pulsatile IV insulin therapy (PROCEDURE), Effects of Pulsatile IV Insulin on Cognitive functions (PROCEDURE).
Who is sponsoring clinical trial NCT00228865?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.